series-c-plus
Stage
About
ChemoCentryx is a U.S. drug-development company focused on discovering and developing therapeutics for inflammatory diseases. The company was listed on NASDAQ in 2012.
Explore ChemoCentryx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.